General MedicationsORALGeneric

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Standard Dose

500MG/15ML;10MG/15ML

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview HYDROCODONE BITARTRATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 040508 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength SOLUTION;ORAL - 500MG/15ML;10MG/15ML Sponsor MALLINCKRODT INC Submission history Latest submission status date: 2003-08-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview HYDROCODONE BITARTRATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 040508 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength SOLUTION;ORAL - 500MG/15ML;10MG/15ML Sponsor MALLINCKRODT INC Submission history Latest submission status date: 2003-08-29 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.